NuGen Medical Devices Inc. announced it has appointed Mr. Ian Heynen as the Company's new Chief Executive Officer, effective November 1, 2023. Mr. Heynen is recognized in the med-tech industry as a top-performing industry executive with over decades of experience leading technology-driven organizations including operational start-ups, turnaround situations, and accelerated growth companies. Mr. Heynen has experience leading and managing P&Ls for North American and International businesses with multi-site divisions and gross revenues of up to $600+ million.

He holds exceptional med-tech commercial execution expertise in creating and implementing compelling strategic plans by building and aligning the organization towards strategic growth objectives to deliver bottom-line results. Most notably, Mr. Heynen was integral to the launch and growth of the start-up Sentinelle Medical, attracting the multinational buyer Hologic Inc. At Hologic Inc., he held multiple positions, culminating in the role of acting President where he was responsible for Europe, Middle East and Africa, Canada, Latin America and the Asia Pacific regions, leading an international business with multi-site divisions and over 1,000 key associates, generating gross revenues of $600+ million. Mr. Heynen holds a CMA-MBA combined program (Graduate Gold Medalist) from Wilfrid Laurier University (Toronto, Ontario), and a Master's in Applied Sciences in Chemical Engineering from the University of British Columbia (Vancouver, British Columbia).

He also holds a Bachelor of Applied Science in Chemical Engineering from the University of Waterloo (Waterloo, Ontario). Mr. Heynen lives in Toronto, Canada with his wife and is a father of 3. He has been a Board Committee Member of Kingsway College School since 2017. Richard Buzbuzian remains President and a Director of NuGen and will continue to focus on capital markets, corporate finance and investor relations initiatives.

Mr. Heynen will focus his attention on fully commercializing the Company with sales and manufacturing capabilities that drive growth, while effectively managing the P&L.